Curis
CRIS
#11024
Rank
โ‚น64.78 M
Marketcap
โ‚น33.24
Share price
-17.89%
Change (1 day)
-78.89%
Change (1 year)

Curis (CRIS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น1.62 Billion

According to Curis's latest financial reports the company's total liabilities are โ‚น1.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Curis - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น1.30 B-67.89%
2024-12-31โ‚น4.05 B-15.46%
2023-12-31โ‚น4.79 B-6.96%
2022-12-31โ‚น5.15 B-3.26%
2021-12-31โ‚น5.32 B-1.12%
2020-12-31โ‚น5.38 B9.5%
2019-12-31โ‚น4.92 B68.15%
2018-12-31โ‚น2.92 B-7.96%
2017-12-31โ‚น3.18 B64.28%
2016-12-31โ‚น1.93 B-4.35%
2015-12-31โ‚น2.02 B-2.73%
2014-12-31โ‚น2.08 B-4.91%
2013-12-31โ‚น2.18 B12.57%
2012-12-31โ‚น1.94 B342.48%
2011-12-31โ‚น0.43 B91.04%
2010-12-31โ‚น0.22 B62.64%
2009-12-31โ‚น0.14 B6.68%
2008-12-31โ‚น0.13 B-51.56%
2007-12-31โ‚น0.27 B-62.26%
2006-12-31โ‚น0.72 B-29.68%
2005-12-31โ‚น1.03 B25.18%
2004-12-31โ‚น0.82 B7.23%
2003-12-31โ‚น0.76 B-63.51%
2002-12-31โ‚น2.10 B-0.25%
2001-12-31โ‚น2.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น11.240 T 690,246.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.365 T 390,818.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น7.75 B 376.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น63.08 B 3,774.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น5.27 B 224.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น1.03 B-36.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น76.46 B 4,595.80%๐Ÿ‡บ๐Ÿ‡ธ USA